The Efficacy of Andrographolide and Its Combination With Betulinic Acid in the Treatment of Triple Negative Breast Cancer

Cancer therapy & Oncology International Journal
doi 10.19080/ctoij.2017.04.555628
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Juniper Publishers

Related search

The Efficacy of Betulinic Acid in Triple-Negative Breast Cancer

SAGE Open Medicine
Medicine
2014English

Cisplatin in Combination With Zoledronic Acid: A Synergistic Effect in Triple-Negative Breast Cancer Cell Lines

International Journal of Oncology
Cancer ResearchOncology
2013English

Cetuximab-Conjugates Nanoparticles for the Treatment of Triple Negative Breast Cancer

2019English

Biology, Metastatic Patterns, and Treatment of Patients With Triple-Negative Breast Cancer

Clinical Cancer Reviews
2009English

Targeting MYC for Triple-Negative Breast Cancer Treatment

Oncoscience
Cancer ResearchOncology
2018English

Triple-Negative Breast Cancer

2018English

Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy Against Triple-Negative Human Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

Combination of GHRH Antagonists and Docetaxel Shows Experimental Effectiveness for the Treatment of Triple-Negative Breast Cancers

Oncology Reports
MedicineCancer ResearchOncology
2013English

The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer

Cancer Management and Research
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy